Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|June 22, 2023
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progressionManuel Gentiluomo, Chiara Corradi, Paolo Giorgio Arcidiacono, et al.
Cancer Chemotherapy and Pharmacology|November 7, 2020
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patientsMarina Macchini, Umberto Peretti, Giulia Orsi, et al.
Annals of Surgical Oncology|March 8, 2024
Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biological R2 Definition"Giulio Belfiori, Stefano Crippa, Michele Pagnanelli, et al.
Clinical and Translational Radiation Oncology|May 23, 2024
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinomaPaolo Passoni, Michele Reni, Sara Broggi, et al.
JAMA Surgery|July 24, 2024
Futility of Up-Front Resection for Anatomically Resectable Pancreatic CancerStefano Crippa, Giuseppe Malleo, Vincenzo Mazzaferro, et al.
Annals of Surgery|August 26, 2025
Prognostic Validation of Perineural Invasion Severity Score in Pancreatic Cancer: A Prospective StudyGiulia Gasparini, Stefano Crippa, Marco Schiavo Lena, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 1, 2021
Main Duct Thresholds for Malignancy Are Different in Intraductal Papillary Mucinous Neoplasms of the Pancreatic Head and Body-TailStefano Crippa, Francesca Aleotti, Enrico Longo, et al.
Pageof 8